Co-founder Andrew Shatté, Ph.D., to take role of Chief Knowledge Officer
Boston, MA (July 9, 2020) – meQuilibrium, the leading human capital solution grounded in the science of resilience, announced that Brad Smith, Ph.D. has joined the senior management team as Chief Science Officer. Dr. Smith will lead meQuilibrium’s active science agenda and research function in the pursuit of scientific advancements to help build workforce potential. Previously, Dr. Smith was Senior Data Scientist at Cigna where he evaluated Cigna products and services and developed a Cigna-wide business intelligence dashboard.
Dr. Smith was formerly with meQuilibrium from 2016-2019 in the role of VP, Data Science, where he was responsible for leading the company’s research advancements in resilience and wellbeing.
Dr. Smith has over two decades of experience in the field of healthcare analytics and research and earned his Ph.D. in quantitative social science at Indiana University Bloomington. Dr. Smith is the author of numerous publications including two seminal, peer-reviewed journal articles in the Journal of Occupational and Environmental Medicine.
In line with this new appointment, meQuilibrium co-founder Andrew Shatté, Ph.D. will take on the role of chief knowledge officer, which will include developing the company’s growing professional services training portfolio as a complement to meQuilibrium’s digital solution and collaborating with Dr. Smith on his research.
“At our core, we are a data and science company with validated insights to identify risk factors and activate employees to seek care,” said Jan Bruce, co-founder and CEO of meQuilibrium. “Brad is a strategic and experienced data scientist and health tech industry expert, with a track record of impactful research studies, who can support the company’s rapid growth and accelerate our value to employers.”
“It’s an exciting time for me to return to meQuilibrium,” says Dr. Smith. “The company is in a unique position to support employers and employees with the best science-based cognitive performance solution. meQuilibrium offers a great opportunity for me to make a difference through research that advances our knowledge of employee behavioral health and wellbeing.”
meQuilibrium has been recognized for its dynamic AI-driven machine learning platform and has been recognized for both product excellence and company growth by organizations such as Deloitte, Inc., TalentCulture, Brandon Hall Group, and others.
meQuilibrium is the engagement, performance, and wellbeing solution that harnesses behavioral psychology, AI, predictive analytics and neuroscience to help innovative businesses build workforce potential. By unlocking the power of resilient people and teams, our customers more successfully navigate even the most turbulent of times. Powered by data-driven insights, our solution uses a clinically-validated assessment and robust benchmarking to measure resilience and create personalized upskilling programs, while providing employers with unique cognitive risk and behavioral health data about their workforce.